Genetic Engineering Market Size, Share, and Trends 2024 to 2034

The global genetic engineering market size is accounted for USD 1.72 billion in 2025 and is forecasted to hit around USD 2.94 billion by 2034, representing a CAGR of 6.15% from 2025 to 2034. The North America market size was estimated at USD 664.20 million in 2024 and is expanding at a CAGR of 6.27% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : April 2025
  • Report Code : 5963
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Genetic Engineering Market 

5.1. COVID-19 Landscape: Genetic Engineering Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Genetic Engineering Market, By Product

8.1. Genetic Engineering Market, by Product

8.1.1. Biochemical

8.1.1.1. Market Revenue and Forecast

8.1.2. Genetic Markers

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global Genetic Engineering Market, By Device

9.1. Genetic Engineering Market, by Device

9.1.1. PCR

9.1.1.1. Market Revenue and Forecast

9.1.2. Gene Gun

9.1.2.1. Market Revenue and Forecast

9.1.3. Gel Assemblies

9.1.3.1. Market Revenue and Forecast

9.1.5.1. Market Revenue and Forecast

Chapter 10. Global Genetic Engineering Market, By Technique 

10.1. Genetic Engineering Market, by Technique

10.1.1. Artificial Selection

10.1.1.1. Market Revenue and Forecast

10.1.2. Gene Splicing

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global Genetic Engineering Market, By Application 

11.1. Genetic Engineering Market, by Application

11.1.1. Medical Industry

11.1.1.1. Market Revenue and Forecast

11.1.2. Agriculture

11.1.2.1. Market Revenue and Forecast

Chapter 12. Global Genetic Engineering Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product  

12.1.2. Market Revenue and Forecast, by Device

12.1.3. Market Revenue and Forecast, by Technique

12.1.4. Market Revenue and Forecast, by Application

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product  

12.1.5.2. Market Revenue and Forecast, by Device

12.1.5.3. Market Revenue and Forecast, by Technique

12.1.5.4. Market Revenue and Forecast, by Application

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product  

12.1.6.2. Market Revenue and Forecast, by Device

12.1.6.3. Market Revenue and Forecast, by Technique

12.1.6.4. Market Revenue and Forecast, by Application

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product  

12.2.2. Market Revenue and Forecast, by Device

12.2.3. Market Revenue and Forecast, by Technique

12.2.4. Market Revenue and Forecast, by Application

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product  

12.2.5.2. Market Revenue and Forecast, by Device

12.2.5.3. Market Revenue and Forecast, by Technique

12.2.5.4. Market Revenue and Forecast, by Application

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product  

12.2.6.2. Market Revenue and Forecast, by Device

12.2.6.3. Market Revenue and Forecast, by Technique

12.2.6.4. Market Revenue and Forecast, by Application

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product  

12.2.7.2. Market Revenue and Forecast, by Device

12.2.7.3. Market Revenue and Forecast, by Technique

12.2.7.4. Market Revenue and Forecast, by Application

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product  

12.2.8.2. Market Revenue and Forecast, by Device

12.2.8.3. Market Revenue and Forecast, by Technique

12.2.8.4. Market Revenue and Forecast, by Application

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product  

12.3.2. Market Revenue and Forecast, by Device

12.3.3. Market Revenue and Forecast, by Technique

12.3.4. Market Revenue and Forecast, by Application

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product  

12.3.5.2. Market Revenue and Forecast, by Device

12.3.5.3. Market Revenue and Forecast, by Technique

12.3.5.4. Market Revenue and Forecast, by Application

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product  

12.3.6.2. Market Revenue and Forecast, by Device

12.3.6.3. Market Revenue and Forecast, by Technique

12.3.6.4. Market Revenue and Forecast, by Application

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product  

12.3.7.2. Market Revenue and Forecast, by Device

12.3.7.3. Market Revenue and Forecast, by Technique

12.3.7.4. Market Revenue and Forecast, by Application

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product  

12.3.8.2. Market Revenue and Forecast, by Device

12.3.8.3. Market Revenue and Forecast, by Technique

12.3.8.4. Market Revenue and Forecast, by Application

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product  

12.4.2. Market Revenue and Forecast, by Device

12.4.3. Market Revenue and Forecast, by Technique

12.4.4. Market Revenue and Forecast, by Application

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product  

12.4.5.2. Market Revenue and Forecast, by Device

12.4.5.3. Market Revenue and Forecast, by Technique

12.4.5.4. Market Revenue and Forecast, by Application

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product  

12.4.6.2. Market Revenue and Forecast, by Device

12.4.6.3. Market Revenue and Forecast, by Technique

12.4.6.4. Market Revenue and Forecast, by Application

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product  

12.4.7.2. Market Revenue and Forecast, by Device

12.4.7.3. Market Revenue and Forecast, by Technique

12.4.7.4. Market Revenue and Forecast, by Application

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product  

12.4.8.2. Market Revenue and Forecast, by Device

12.4.8.3. Market Revenue and Forecast, by Technique

12.4.8.4. Market Revenue and Forecast, by Application

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product  

12.5.2. Market Revenue and Forecast, by Device

12.5.3. Market Revenue and Forecast, by Technique

12.5.4. Market Revenue and Forecast, by Application

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product  

12.5.5.2. Market Revenue and Forecast, by Device

12.5.5.3. Market Revenue and Forecast, by Technique

12.5.5.4. Market Revenue and Forecast, by Application

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product  

12.5.6.2. Market Revenue and Forecast, by Device

12.5.6.3. Market Revenue and Forecast, by Technique

12.5.6.4. Market Revenue and Forecast, by Application

Chapter 13. Company Profiles

13.1. Thermo Fisher Scientific Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Lonza

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Cibus

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Abbott

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Recombinetics Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Sangamo

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Merck KGaA

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Precision Biosciences

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. OriGene Technologies Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Intellia Therapeutics Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global genetic engineering market size is expected to grow from USD 1.62 billion in 2024 to USD 2.94 billion by 2034.

The genetic engineering market is anticipated to grow at a CAGR of 6.15% between 2025 and 2034.

The major players operating in the genetic engineering market are Thermo Fisher Scientific Inc., Lonza, Cibus, Recombinetics Inc., Sangamo, Merck KGaA, Precision Biosciences, OriGene Technologies Inc., Intellia Therapeutics Inc., Caribou Biosciences Inc. ,and Others.

The driving factors of the genetic engineering market are the increasing government grants and funding to biotech startups. The rising production of vaccines and biologics further contributes to market growth.

North America region will lead the global genetic engineering market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client